A Review on Finasteride: A 5-Alpha Reductase Inhibitors, its Mechanism, Facts and Benefits
Shraddha T. Nemane, Omprakash G. Bhusnure, Sachin B. Gholve, Pooja R. Mitakari, Pawan N. Karwa
Abstract
Shraddha T. Nemane, Omprakash G. Bhusnure, Sachin B. Gholve, Pooja R. Mitakari, Pawan N. Karwa
Abstract
This review gives the information about the Finasteride i.e. 5alpha-reductase inhibitor. Primarily finasteride isused to treat BPH i.e benign prostatic hyperplasia and male androgenetic alopecia. Five-alpha reductase inhibitors (5α-RIs) could stimulate male sexual dysfunction due to their effects on testosterone and DHT i.e. dihydrotestosterone. Some studies account insignificant or acceptable adverse effects, which decrease after a changeable period of time so that they do not require terminating finasteride administration. The 5alpha-reductase inhibitor finasteride blocks the conversion of TT to DHT i.e. testosterone to dihydrotestosterone (DHT), the androgen responsible for androgenetic alopecia i.e. male pattern hair loss. This paper presents a possible explanation of the Finasteride drug. Keywords: Finasteride, 5alpha-reductase inhibitor, BPH, DHT, alopecia.
OpenAlex reports 10 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This review gives the information about the Finasteride i.e. 5alpha-reductase inhibitor. Primarily finasteride isused to treat BPH i.e benign prostatic hyperplasia and male androgenetic alopecia. Five-alpha reductase inhibitors (5α-RIs) could stimulate male sexual dysfunction due to their effects on testosterone and DHT i.e. dihydrotestosterone. Some studies account insignificant or acceptable adverse effects, which decrease after a changeable period of time so that they do not require terminating finasteride administration. The 5alpha-reductase inhibitor finasteride blocks the conversion of TT to DHT i.e. testosterone to dihydrotestosterone (DHT), the androgen responsible for androgenetic alopecia i.e. male pattern hair loss. This paper presents a possible explanation of the Finasteride drug. Keywords: Finasteride, 5alpha-reductase inhibitor, BPH, DHT, alopecia.
Key concepts: Finasteride, 5 Alpha-Reductase Inhibitor, Mechanism (biology), Alpha (finance), Chemistry, Pharmacology, Medicine, Internal medicine